INTERLEUKIN-8 IN SEPSIS - RELATION TO SHOCK AND INFLAMMATORY MEDIATORS

被引:275
作者
HACK, CE
HART, M
VANSCHIJNDEL, RJMS
EERENBERG, AJM
NUIJENS, JH
THIJS, LG
AARDEN, LA
机构
[1] UNIV AMSTERDAM,EXPTL CLIN IMMUNOL LAB,1066 CX AMSTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM HOSP,MED INTENS CARE UNIT,1081 HV AMSTERDAM,NETHERLANDS
关键词
D O I
10.1128/IAI.60.7.2835-2842.1992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because of its neutrophil-activating properties, interleukin-8 (IL-8) may play an important role in the pathophysiology of sepsis. We measured circulating IL-8 levels in 47 patients with clinical sepsis. Levels on admission were elevated in 42 of the 47 patients (89%) and were comparable in patients with gram-positive or gram-negative infections. Patients with shock had significantly higher IL-8 levels than normotensive patients (P = 0.0014, Wilcoxon-Mann-Whitney test), whereas no differences in IL-8 levels were found between patients with or without adult respiratory distress syndrome. Patients who died had higher IL-8 levels on admission than the patients who survived. The largest differences in IL-8 levels between survivors and nonsurvivors was found when only patients with positive cultures were considered (P = 0.0342). IL-8 levels appeared to correlate significantly with lactate levels and inversely with leukocyte and platelet numbers and mean arterial pressure. In addition, the IL-8 level in the sepsis patients was found to correlate significantly with levels of IL-6, elastase-alpha-1-antitrypsin, and C3a. Serial observations revealed that in most patients IL-8 levels decreased, irrespective of the outcome. Thus, our results demonstrate that IL-8 levels are increased in most patients with sepsis and correlate with some important clinical, biochemical, and inflammatory parameters. These findings suggest a role for IL-8 in the pathophysiology of sepsis.
引用
收藏
页码:2835 / 2842
页数:8
相关论文
共 57 条
[41]   PLASMA NEUTROPHIL-ACTIVATING PEPTIDE-1/INTERLEUKIN-8 AND NEUTROPHIL ELASTASE IN A PRIMATE BACTEREMIA MODEL [J].
REDL, H ;
SCHLAG, G ;
BAHRAMI, S ;
SCHADE, U ;
CESKA, M ;
STUTZ, P .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (02) :383-388
[43]  
SCHRODER JM, 1987, J IMMUNOL, V139, P3473
[44]  
STARNES HF, 1990, J IMMUNOL, V145, P4185
[45]   PROMOTION AND SUBSEQUENT INHIBITION OF PLASMINOGEN ACTIVATION AFTER ADMINISTRATION OF INTRAVENOUS ENDOTOXIN TO NORMAL SUBJECTS [J].
SUFFREDINI, AF ;
HARPEL, PC ;
PARRILLO, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1165-1172
[46]   SHOCK AND TISSUE-INJURY INDUCED BY RECOMBINANT HUMAN CACHECTIN [J].
TRACEY, KJ ;
BEUTLER, B ;
LOWRY, SF ;
MERRYWEATHER, J ;
WOLPE, S ;
MILSARK, IW ;
HARIRI, RJ ;
FAHEY, TJ ;
ZENTELLA, A ;
ALBERT, JD ;
SHIRES, GT ;
CERAMI, A .
SCIENCE, 1986, 234 (4775) :470-474
[47]  
TRACEY KJ, 1987, SURG GYNECOL OBSTET, V164, P415
[48]   ANTI-CACHECTIN TNF MONOCLONAL-ANTIBODIES PREVENT SEPTIC SHOCK DURING LETHAL BACTEREMIA [J].
TRACEY, KJ ;
FONG, Y ;
HESSE, DG ;
MANOGUE, KR ;
LEE, AT ;
KUO, GC ;
LOWRY, SF ;
CERAMI, A .
NATURE, 1987, 330 (6149) :662-664
[49]   A NOVEL, NH2-TERMINAL SEQUENCE CHARACTERIZED HUMAN MONOKINE POSSESSING NEUTROPHIL CHEMOTACTIC, SKIN-REACTIVE, AND GRANULOCYTOSIS-PROMOTING ACTIVITY [J].
VANDAMME, J ;
VANBEEUMEN, J ;
OPDENAKKER, G ;
BILLIAU, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1364-1376
[50]  
VANDAMME J, 1991, CYTOKINE HDB IMMUNOL, P201